We are live on ! Find out more
NVAX icon

Novavax

117 hedge funds and large institutions have $180M invested in Novavax in 2020 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 42 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

614% more first-time investments, than exits

New positions opened: 50 | Existing positions closed: 7

567% more capital invested

Capital invested by funds: $27M → $180M (+$153M)

320% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 10

52% more funds holding

Funds holding: 77117 (+40)

15% more call options, than puts

Call options by funds: $20.3M | Put options by funds: $17.6M

0.52% more ownership

Funds ownership: 24.97%25.49% (+0.52%)

Holders
117
Holders Change
+40
Holders Change %
+51.95%
% of All Funds
2.58%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
50
Increased
42
Reduced
10
Closed
7
Calls
$20.3M
Puts
$17.6M
Net Calls
+$2.66M
Net Calls Change
-$3.19M

NVAX Hedge Fund Activity: Q1 2020 in Review

117 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q1 2020, worth a combined $180M — up 567% from $27M a quarter earlier.

Buyers outnumbered sellers: 50 funds opened new NVAX positions and 7 closed out — a net gain of 43 holders — while 42 added to existing stakes and 10 trimmed.

The largest buyer was Franklin Resources, opening a new position worth an estimated $14.6M. The largest seller was Group One Trading, cutting an estimated $542K.

  • 117 institutional investors held Novavax (NVAX) as of Q1 2020, up from 77 in Q4 2019.
  • Funds reported $180M of Novavax stock for Q1 2020, up 567% quarter-over-quarter.
  • 50 funds opened new Novavax positions in Q1 2020 and 7 closed out, a net change of +43 holders.
  • The largest Novavax buyer in Q1 2020 was Franklin Resources, an estimated $14.6M added.
  • The largest Novavax seller in Q1 2020 was Group One Trading, an estimated $542K sold.

Based on aggregated 13F filings for Q1 2020.